gs1 03 discussant hope s rugo
Published 1 year ago • 43 plays • Length 14:56Download video MP4
Download video MP3
Similar videos
-
16:21
dr. hope rugo | san antonio breast cancer symposium 2022 | general session
-
9:59
gs1-01: "phase 3 study of pembrolizumab chemotherapy vs placebo chemotherapy as neoadjuvant..."
-
2:35
dr. hope rugo previews the 2012 san antonio breast cancer symposium program
-
9:06
hope s. rugo: calgb 40502/ncctg n063h
-
10:49
gs1-09: "inhibition of gpx4 induces preferential death of p53-mutant triple negative breast..."
-
2:26
anti-angiogenesis - antiangiogenesis
-
1:35:38
ucsf bay area breast cancer forum: "updates from asco 2024”
-
12:46
the only metastatic cancer survivor retreat of its kind
-
1:53
dr. hope rugo examines angiogenesis inhibition for advanced breast cancer
-
0:59
ribociclib in adjuvant hr breast cancer
-
35:27
dr. hope rugo – esmo 2022 – exploring the latest trial data & advances in breast cancer treatments
-
9:41
gs1-02: "randomized, double-blind, phase 3 study of pembrolizumab chemotherapy vs placebo..."
-
10:09
hope rugo, md: advances and challenges in the treatment of metastatic breast cancer
-
4:08
prospects in the management of breast cancer
-
0:59
dr. rugo on pi3k and mtor inhibitors for the treatment of breast cancer
-
7:31
hope rugo, md: young women with breast cancer and neo-adjuvent chemotherapy
-
7:13
hope rugo, md: chemotherapy agents and breast cancer treatment
-
1:11
dr. rugo on the significance of the monarch i trial for breast cancer
-
1:15
dr. rugo discusses the future of angiogenesis in breast cancer
-
1:24
dr. rugo on extended adjuvant hormone therapy for breast cancer
-
1:28
hope s. rugo on the approval of the cooling cap